RBM5 and non-small cell lung carcinoma: There is increasing evidence suggesting that downregulation of RBM5 plays an important role in NSCLC occurrence, progression, metastasis, and drug resistance[16, 18, 21, 22, 25, 26], yet the mechanisms are still not well clarified.